AdaptHealth Corp. Common Stock (AHCO) is a publicly traded Healthcare sector company. As of November 3, 2026, AHCO trades at $5.89 with a market cap of $775.11M and a P/E ratio of -10.77. AHCO moved +3.55% today. Year to date, AHCO is -38.83%; over the trailing twelve months it is -34.20%. Its 52-week range spans $5.21 to $13.43. Analyst consensus is strong buy with an average price target of $9.40. Rallies surfaces AHCO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AdaptHealth raises revenue and EBITDA outlook, cuts free cash flow forecast after Q3 loss: AdaptHealth reported Q3 revenue of $745.65 million, up 10.9%, and a net loss of $152.77 million that included a $184.8 million goodwill impairment. It raised 2026 revenue and adjusted EBITDA guidance but lowered its free cash flow forecast to $50 million-$75 million.
| Metric | Value |
|---|---|
| Price | $5.89 |
| Market Cap | $775.11M |
| P/E Ratio | -10.77 |
| EPS | $-0.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.43 |
| 52-Week Low | $5.21 |
| Volume | 1.06M |
| Avg Volume | 0 |
| Revenue (TTM) | $3.24B |
| Net Income | $-66.04M |
| Gross Margin | 18.77% |
6 analysts cover AHCO: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.40.